We are live on ! Find out more
LLY icon

Eli Lilly

1,005 hedge funds and large institutions have $42.1B invested in Eli Lilly in 2013 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 341 increasing their positions, 406 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 69

11% more call options, than puts

Call options by funds: $460M | Put options by funds: $416M

3% more funds holding

Funds holding: 9741,005 (+31)

2% more capital invested

Capital invested by funds: $41.1B → $42.1B (+$950M)

0.62% more ownership

Funds ownership: 72.69%73.31% (+0.62%)

16% less repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 406

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

Holders
1,005
Holders Change
+31
Holders Change %
+3.18%
% of All Funds
29.16%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.55%
New
112
Increased
341
Reduced
406
Closed
69
Calls
$460M
Puts
$416M
Net Calls
+$44.3M
Net Calls Change
-$109M
Name Holding Trade Value Shares
Change
Change in
Stake
BG
226
Bollard Group
Massachusetts
$11.7M +$181K +3,619 +2%
MACM
227
March Altus Capital Management
Connecticut
$11.6M +$11.4M +226,838 New
Bank of Nova Scotia
228
Bank of Nova Scotia
Ontario, Canada
$11.5M +$4.47M +89,360 +66%
AA
229
ALPS Advisors
Colorado
$11.3M +$2.87M +57,247 +37%
GT
230
Glenview Trust
Kentucky
$11.2M +$11M +219,652 New
OPERF
231
Oregon Public Employees Retirement Fund
Oregon
$11M +$3.95M +78,800 +57%
AG
232
Aperio Group
California
$10.9M -$11.4M -227,403 Closed
ProShare Advisors
233
ProShare Advisors
Maryland
$10.9M +$5.67M +113,258 +113%
Nomura Asset Management
234
Nomura Asset Management
Japan
$10.9M -$3.64M -72,710 -25%
ORIO
235
Old Republic International (ORI)
Illinois
$10.8M +$10.6M +212,000 New
BC
236
Blackhill Capital
New Jersey
$10.7M
KeyBank National Association
237
KeyBank National Association
Ohio
$10.3M -$78.2K -1,562 -0.8%
HNB
238
Huntington National Bank
Ohio
$10.3M +$1.95M +38,900 +24%
OTPPB
239
Ontario Teachers' Pension Plan Board
Ontario, Canada
$10.2M -$1.96M -39,084 -16%
JCP
240
Jabre Capital Partners
Switzerland
$10.2M +$3.25M +65,000 +48%
Acadian Asset Management
241
Acadian Asset Management
Massachusetts
$10M -$79M -1,578,321 -89%
STC
242
SEI Trust Company
Pennsylvania
$9.99M -$4.91M -97,970 -33%
BCM
243
Bridgeway Capital Management
Texas
$9.84M +$6.34M +126,700 +191%
COPPSERS
244
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$9.65M -$663K -13,245 -7%
Mitsubishi UFJ Asset Management
245
Mitsubishi UFJ Asset Management
Japan
$9.57M -$3.27M -65,257 -26%
M&T Bank
246
M&T Bank
New York
$9.46M +$1.35M +27,036 +17%
Asset Management One
247
Asset Management One
Japan
$9.32M -$2.97M -59,339 -25%
V
248
ValueWorks
New York
$9.32M +$5.45M +108,893 +147%
Fifth Third Bancorp
249
Fifth Third Bancorp
Ohio
$9.23M -$260K -5,198 -3%
ANI
250
American National Insurance
Texas
$9.12M

LLY Hedge Fund Activity: Q4 2013 in Review

1,005 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2013, worth a combined $42.1B — up 2.3% from $41.1B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LLY positions and 69 closed out — a net gain of 43 holders — while 341 added to existing stakes and 406 trimmed.

The largest buyer was Franklin Resources, adding an estimated $711M. The largest seller was Fidelity Investments, cutting an estimated $141M.

  • 1,005 institutional investors held Eli Lilly (LLY) as of Q4 2013, up from 974 in Q3 2013.
  • Funds reported $42.1B of Eli Lilly stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 112 funds opened new Eli Lilly positions in Q4 2013 and 69 closed out, a net change of +43 holders.
  • The largest Eli Lilly buyer in Q4 2013 was Franklin Resources, an estimated $711M added.
  • The largest Eli Lilly seller in Q4 2013 was Fidelity Investments, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.